Intracranial Aneurysm Market

Intracranial Aneurysm Market Outlook (2025 to 2035)

The global intracranial aneurysm market is expected to reach USD 4,903 million by 2035, up from USD 1,626 million in 2024. During the forecast period (2025 to 2035), the industry is projected to expand at a CAGR of 10.5%.

Over the span of next ten years, the industry is poised to grow 2.7X with an absolute dollar opportunity of USD 3,096 million. This growth reflects advances in minimally invasive treatments, rising awareness, and expanding neurovascular innovation globally.

Intracranial aneurysm refers to aneurysmatic dilatation or expansion of cerebral artery walls by degenerate arteries. Intracranial aneurysm may rupture and cause fatal conditions such as subarachnoid hemorrhage or stroke. The most suitable imaging and diagnosis for this would be cerebral angiography, MRI, or CT angiography. Therapy procedures that may be attempted include surgical clipping, endovascular coiling, and use of flow diversion device.

What are the drivers of the Intracranial Aneurysm Market?

Epidemiological rate of growth of intracranial aneurysm and rising awareness of early diagnosis are the major drivers of growth of the intracranial aneurysm market.

The advanced neuroimaging modalities such as computed tomography angiography (CTA) and magnetic resonance angiography (MRA) are making the diagnosis early, thus the incidence of cases being detected is on the rise, and thereby treatment becomes the need of the hour. Apart from that, the world's elderly population, which is highly susceptible to cerebrovascular disorders, is also propelling the market's growth.

One of the key trends is moving towards more use of minimally invasive treatment. Flow-diverting stents and endovascular coiling are becoming more common treatment protocols since they allow patients to heal faster than traditional modes of surgery and do not develop complications as often. Greater market growth due to greater availability of complex embolization devices and bioresorbable flow diverters in the market is also profitable for market growth

Healthcare expenditure expansion and hospital center establishment, particularly in the emerging markets, are expanding the accessibility of aneurysm treatment. Government campaigns to increase awareness of neurological diseases and investments in brain health research are also driving the market growth.

Pharmas and device makers are spending heavily on R&D to bring new treatment platforms and agents to the market, such as new embolization devices and neuroprotective therapy. Increasing incidence of risk factors such as hypertension, smoking, and hereditary aneurysm is also fueling market growth. Telemedicine and AI use for diagnosis will also increase screening and treatment efficacy and maintain robust market growth.

Metric	Value
Industry Size (2025E)	USD 1,807 million
Industry Value (2035F)	USD 4,903 million
CAGR (2025 to 2035)	10.5%

What are the regional trends of the Intracranial Aneurysm Market?

Intracranial aneurysm market accounts for the maximum share in the North American region because of the highly developed healthcare infrastructure and high rates of awareness regarding neurological diseases. The U.S. market is the biggest here because of the government-initiated stroke prevention programs and massive R&D costs incurred by medical device firms.

The extensive application of neurovascular devices and artificial intelligence for image diagnosis is also propelling this market. Apart from this, favorable reimbursement policies and the presence of industry players are also contributing to North America leading this market.

Europe too is witnessing growth that is constant and growth is realized through a growing population and positive reimbursement policies. The leading nations in the treatment of aneurysms are Germany, France, and the U.K. and these possess a massive inclination towards creating innovative solutions in neurovascular areas. European Union regulations are stringent to maintain efficacy as well as safety and this is an added pull of creating improved solution treatments.

Asia-Pacific is expanding at the highest pace with increasing investment in the healthcare industry, increasing disposable incomes, and increasing diagnostic potential. Japan, China, and India have the highest growth demand for neurovascular procedures due to increasing cerebrovascular disease incidence. Government efforts in managing stroke and increasing private healthcare centers are also driving the market.

Middle East & Africa is gradually expanding with growing awareness of neurological disorders and development of health infrastructure. Investment in sophisticated medical equipment is becoming more feasible as a treatment option in Gulf Cooperation Council (GCC) nations, while in Africa, foreign partnerships are filling the gaps for specialty neurology treatment.

What are the challenges and restraining factors of the Intracranial Aneurysm Market?

The expense of treatment and of devices is one of the biggest intracranial aneurysm market challenges. Embolization and flow diversion are extremely expensive procedures due to the material and human factor involved and thus cannot be afforded by poor patients. That is further compounded by the lack of general insurance of minimally invasive treatments for most nations.

Regulatory restrictions restrain the development of the market as neurovascular devices have to go through severe approval processes, particularly in the US and EU. Problem of compliance will retard product launch and increase the R&D expense of manufacturers.

Shortage of specialist interventional neuroradiologists and neurosurgeons still keeps transitional health facilities in developing countries from adopting newer technologies. Recurrence, complication of thrombosis, and device migration issues still persist despite technological advancements.

Shifts in the Intracranial Aneurysm Market from (2020 to 2024) and Future Trends (2025 to 2035)

Intracranial aneurysm market size grew tremendously between the years 2020-2024 with a rise in minimally invasive treatments, increased awareness of early detection, and advanced neurovascular imaging technology. Rising incidence among older people and hypertensive patients has also seen increased utilization of new treatments like flow diverters, embolization coils coils, and stents.

The next ten years of the market will see revolution with artificial intelligence (AI) diagnostics, second-generation stent and coil biomaterials, and customized modalities for individualized medicine. Growing utilization of robotic surgeries and rising healthcare investments in the direction of neurovascular disease will fuel market activities.

Market Shift	2020 to 2024
Regulatory Landscape	Regulations focused on the safety and efficacy of medical devices, with approvals from agencies like the FDA and EMA. Standardization of clinical guidelines for endovascular treatments.
Technological Advancements	Adoption of flow diverters, embolization coils, and neurovascular stents. Development of 3D imaging for accurate aneurysm detection.
Industry-Specific Demand	High demand from neurology and neurosurgery centers. Growing awareness about early detection in at-risk populations.
Sustainability & Circular Economy	Initial steps toward biocompatible materials for neurovascular implants. Recycling initiatives in medical device manufacturing.
Production & Supply Chain	Supply chain disruptions affecting access to critical neurovascular implants. Increasing reliance on major global manufacturers.
Market Growth Drivers	Rising cases of intracranial aneurysms due to lifestyle diseases and aging populations. Technological improvements in neuroimaging and endovascular procedures.

Market Shift	2025 to 2035
Regulatory Landscape	Stricter policies on medical device safety, with increased emphasis on long-term patient outcomes. Greater oversight on AI-based diagnostic tools and personalized treatment plans.
Technological Advancements	AI-powered diagnostic tools for early-stage aneurysm identification. Advancements in bioresorbable stents and nanotechnology-based treatments. Increased use of robotic-assisted neurovascular interventions.
Industry-Specific Demand	Expansion into personalized and AI-driven treatment strategies. Increased demand for outpatient endovascular treatments due to reduced hospitalization costs.
Sustainability & Circular Economy	Development of fully biodegradable stents. Stronger emphasis on reducing the carbon footprint of medical device production.
Production & Supply Chain	Decentralized and localized production of neurovascular implants using 3D printing. AI-driven supply chain optimization for better inventory management.
Market Growth Drivers	Integration of AI for predictive analytics in aneurysm rupture risks. Increased adoption of remote patient monitoring and digital health solutions for post-surgical care.

Future Outlook (2025 to 2035)

The intracranial aneurysm market will revolutionize competitively with the integration of AI, robotics, and biomaterial technologies. AI, enhancing early detection rates, will also offer predictive analytics to quantify aneurysm rupture risk with accuracy. Robot-assisted neurosurgery, on the other hand, will enhance precision in endovascular treatment by reducing complications and healing time.

Besides, nanotechnology and biodegradable implants will further render the treatment more with better and less harmful substitutes. As health care policies are reformed, reimbursement practices would also be focused towards minimally invasive techniques, thus becoming cost-effective for most of the patients.

With greater emphasis on patient-specific treatment and e-health, the coming decade will be a revolution in the diagnosis, treatment, and follow-up of intracranial aneurysms, saving health costs and enhancing patients' long-term outcome.

Country-Wise Insights

Country	Attributes
United States (CAGR %)	9.7%
Germany (CAGR %)	10.8%
China (CAGR %)	11.0%

United States (U.S.)

The U.S. market for intracranial aneurysm is expanding with rising neurovascular therapeutics, improved understanding of neurological disorders, and rising numbers of geriatric patients. Greater adoption of minimally invasive treatments such as flow diverters and embolization coils is enhancing patient outcome and lowering rates of postoperative complication. New FDA approvals for neurovascular devices, growing expenditures on the manufacturing of bioresorbable stents, and diagnostic technologies with AI are fueling the market.

The advanced health infrastructure of the United States, higher health expenditure, and liberal reimbursement policies are conducive to the adoption of new treatment methods for aneurysm treatment. In addition, research institute-hospital-biotech company collaborations are driving medical innovations with growing uses of AI-based imaging for earlier detection. With the presence of the industry leaders and robotic neurosurgies technologies, the United States is a trendsetter in the global intracranial aneurysm market.

Germany

Germany's intracranial aneurysm market is growing at a highly high growth rate with the country's improved healthcare infrastructure, rising incidence of cerebrovascular disorders, and higher government funding for neurological research. Systematic implementation of robot-supported neurointerventional therapy and AI-supported treatment planning is revolutionizing aneurysm therapy, improving accuracy, and reducing surgery-related complications.

Favorable reimbursement policy and Germany's national health system minimize the affordability of costly neurovascular procedures, and hence make them available to more people, thus expanding market penetration. Collaborative research among research institutions and medical device companies is leading the innovation with aneurysm treatment devices such as bioabsorbable stents and flow-diversion technology. Also under observation are non-invasive diagnostic technologies such as 3D angiography and AI imaging which are equal to early diagnosis and enhanced patient outcomes. Eager to adopt personalized medicine and medicine AI, Germany is a leading European intracranial aneurysm treatment market with huge investments from foreign and local medical device firms.

China

The intracranial aneurysm market in China is expanding rapidly with more and more elderly citizens, greater awareness of neurovascular disease, and more health investment. Government programs such as Healthy China 2030 Plan are also expanding the supply of high-level neurointerventional therapy by several times, thereby propelling the demand of the market. The presence of native manufacturers of medical devices is making cost-effective options available, and hence aneurysm treatment is becoming feasible across different economic segments.

Moreover, the innovation of AI-driven imaging solutions, hydrophilic-coated catheter solutions, and aneurysm model therapy using 3D printing is transforming China's neurovascular therapy market. Greater medical tourism business, as well as improved health infrastructure is further making China a gargantuan market for new aneurysm treatment. In addition, increased application of robot-assisted procedures and smart diagnostic systems is further fueling precision and outcomes. With government encouragement and rapid growth in the healthcare services sector, China is becoming a center for the treatment and research of intracranial aneurysm worldwide.

Category-Wise Analysis

Endovascular Coiling - By Type

Endovascular Coiling segment is underpinned by strong growth because of the minimally invasive nature of treatment and the success rate in preventing rupture of aneurysm. The treatment means deployment of platinum coils inside the aneurysm and clotting, occlusion of blood flow, and rupture prevention.

Key drivers for growth in this segment are higher use of endovascular treatment, technology advancements in coil material and deployment systems, and higher awareness among neurosurgeons about the advantages of coiling over open surgery clipping. Higher detection of unruptured aneurysms with the help of advanced imaging techniques is influencing demand for coiling procedure at a higher rate.

Future growth in the segment is with the launch of bioactive and hydrogel-coated coils for aneurysm treatment and AI-based navigation systems for accurate placement. With the follow-up uptilts in neurovascular treatment technology and universalization of access to health in emerging economies, endovascular coiling market growth will be consistent.

Hospitals - By End User

Hospitals have a monopoly intracranial aneurysm business because of the choice location for emergent and elective treatment aneurysm repair. Hospitals have sophisticated neurovascular units with the latest imaging and surgery technology and procedure capacity, best equipped to repair aneurysms.

The key growth drivers in this segment include increasing hospitalization of aneurysm, availability of highly skilled neurosurgeons, and government subsidies to create infrastructure in the event of the treatment of stroke and aneurysm. In addition, the use of hybrid operating rooms that leverage the strength of surgery and angiography is enhancing the quality of treatment.

Growth of the segment further will depend on the use of AI-based diagnostic techniques for the detection of expanding aneurysms, robot-assisted neurointerventional therapy, and online hemodynamic monitoring in an effort to have improved outcomes. With the maturity of health infrastructure in each part of the world, particularly in the developing countries, the hospitals will become leaders in adopting the treatment of aneurysms and hence drive the market further to expand.

Saccular Aneurysms - By Indication

Market for Saccular Aneurysms is moderately increasing and the most common type of intracranial aneurysm to be diagnosed is saccular aneurysm. Saccular aneurysm has higher chances of rupture due to spherical shape and thus needs to be operated in the initial stage with endovascular or open surgery.

Some of the drivers for the market include growing cases of aneurysm and hypertension induced by smoking, development of imaging technology, which has made it easy to produce good diagnostics from the very outset, growing desire for less invasive approaches like coiling and flow diversion, and avoiding screening for risky patients progressively becoming vital and fueling the market.

Future growth involves high-end bioengineered embolic device production for aneurysm occlusion and risk stratification artificial intelligence solutions to aid physicians with high-end solutions. Increased R&D investment in developing personalized solutions to treat aneurysms will put the saccular aneurysms segment on the path of improvement in the short term.

Competitive Analysis

Key players in the Intracranial Aneurysm (IA) Market include B. Braun Melsungen AG, Integra LifeSciences Corporation, Johnson & Johnson, Medtronic, MicroPort Scientific Corporation, Raumedic AG, Stryker, Terumo Corporation, MicroVention, Inc., and Balt.

There is a growing need with a rise in intracranial aneurysm cases, neurovascular surgical treatment being less invasive, and greater demand for successful treatment. Flow diverters, embolic coils, and stent-assisted coiling are a few of the newer devices that have been the major contributory factor towards the outcome and have made the treatment option more feasible. ​

Companies are focusing on developing devices with enhanced safety profiles, improved delivery systems, and better conformability to complex aneurysm anatomies. In addition, there is a growing emphasis on integrating advanced imaging technologies and robotics to enhance precision in surgical interventions.

• On February 2025, Penumbra launched the ACCESS25™ Delivery Microcatheter, enhancing neurovascular access for efficient aneurysm embolization. Designed for precision and stability, it supports Penumbra’s .020” coil platform, ensuring improved trackability, reduced procedure time, and superior coil deployment. Available in multiple tip shapes, ACCESS25 optimizes complex neurovascular procedures.
• On December 2023, Mayo Clinic expanded aneurysm treatment options with advanced devices, including anti-thrombotic stents and intrasaccular flow disruptors. These innovations reduce thrombosis risk, enhance occlusion in complex aneurysms, and minimize the need for blood thinners. Mayo Clinic remains committed to safer, less invasive, and more effective aneurysm care.

Market Share Analysis by Company

Company Name	Estimated Market Share (%)
Top 5 Players	~50-60%
Tier II Players	~20-30%
Other Players	~10-20%

Key Company Offerings and Activities

Company Name	Key Offerings/Activities
B. Braun Melsungen AG	Provides advanced neurosurgical instruments and implants; focuses on patient safety and innovative treatment solutions.
Integra LifeSciences Corporation	Offers a range of neurosurgical products, including dural repair grafts and intracranial access systems; emphasizes minimally invasive solutions.
Johnson & Johnson	Through its CERENOVUS brand, delivers innovative neurovascular devices such as embolic coils and stents; invests in research and development for stroke care.
Medtronic	Develops cutting-edge neurovascular technologies, including flow diversion systems and embolization devices; prioritizes clinical research and education.
MicroPort Scientific Corporation	Specializes in minimally invasive neurovascular devices; focuses on expanding global reach and product diversification.
Raumedic AG	Produces customized polymer components for neurosurgical applications; emphasizes biocompatibility and precision engineering.
Stryker	Offers comprehensive neurovascular intervention products, including detachable coils and stent retrievers; invests in clinical studies to improve outcomes.

Medtronic

Medtronic is at the forefront of neurovascular technology, including next-generation flow diversion technology, embolization, and stent-assisted coiling for the treatment of intracranial aneurysm. Medtronic is investing in the future of care, physician education, and clinical studies to enable patient outcomes at their best. Medtronic is growing globally by acquisition. and strategic partnership.

Johnson & Johnson (CERENOVUS)

CERENOVUS is a Johnson & Johnson MedTech business committed to aneurysm and stroke treatment innovation through its neurovascular product platforms such as embolic coils and stenting systems. CERENOVUS spends heavily on R&D, clinical trials, and physician education to create less invasive treatments and refine them to make them safe and effective.

Stryker

Stryker is among the top neurovascular intervention firms that has a big family of detachable coils, stent retrievers, and flow diverters in aneurysm treatment. Committed to procedural efficacy and outcome for the patient, Stryker is embarking on research-led innovation and collaboration with clinicians for a mission of continuously improving its neurovascular technology platform.

MicroPort Scientific Corporation

MicroPort Scientific Corporation is a fast-growing medical device company committed to minimally invasive neurovascular devices. MicroPort is committed to improving aneurysm treatment for more individuals worldwide and emerging markets. MicroPort is expanding in neurovascular by investing in product, clinical trials, and partnership.

Terumo Corporation

Terumo Corporation possesses neurovascular intervention leadership, accuracy of microcatheter, guidewire, and embolization device available in the market. Terumo seeks to practice neurointerventional therapy through technological innovation, educational program of doctors, and professional management of patient safety. Terumo achieves global market presence through co-development and co-research.

Market Outlook

Intracranial aneurysm market is expanding with strong rate owing to increasing awareness, enhancement in minimally invasive therapies, and increasing population at risk of aneurysm. Demand is fueled by increasing adoption of neurovascular devices such as embolic coils, flow diverters, and intrasaccular implants.

Technological advancement in bioresorbable scaffolds technologies, artificial intelligence imaging technology, and robotic-assisted surgery are revolutionizing the area of aneurysm treatment. Meanwhile, the companies are engaged in enhancing safety, precision, and product accessibility in under-penetrated markets. The most innovative region is North America with robust healthcare infrastructure and established reimbursement policy, followed by growth region of the Asia-Pacific market with rising healthcare expenditure and patient population.

Competition is being reshaped by inorganic growth through regulatory approval, strategic purchase, and resident-level training. Technology upgrading and investment in clinical trials, intracranial aneurysm market will experience homogeneous growth with better patient outcome and procedure success across the world.

Fact.MR has provided detailed information about the price points of key manufacturers of Intracranial Aneurysm Market positioned across regions, sales growth, production capacity, and speculative technological expansion, in the recently published report.

Segmentation of Intracranial Aneurysm Market

• By Type :

  • Endovascular Coiling
  • Flow Diverters
  • Surgical Clipping
  • Others

• By End User :

  • Hospitals
  • Clinics
  • Others

• By Indication :

  • Saccular Aneurysms
  • Fusiform Aneurysms
  • Mycotic Aneurysms
  • Others

• By Region :

  • North America
  • Latin America
  • Western Europe
  • Eastern Europe
  • East Asia
  • South Asia & Pacific
  • Middle East & Africa